Huadong Medicine's (SHE:000963) attributable profit rose 9.6% to 1.00 billion yuan in the first half from 914.7 million yuan in the year-ago period, according to a Thursday filing with the Shenzhen bourse.
Earnings per share at the drug maker increased 9.6% to 0.5715 yuan from 0.5213 yuan in the previous year.
Operating revenue grew 4.2% year over year to 11.2 billion yuan from 10.7 billion yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments